ログイン
言語:

WEKO3

  • トップ
  • ランキング
To

Field does not validate

To

Field does not validate

To
lat lon distance


インデックスリンク

インデックスツリー

  • RootNode

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. Public
  2. 学位論文
  3. 博士論文2020.3~

β3-Adrenergic receptor blockade reduces mortality in endotoxin-induced heart failure by suppressing induced nitric oxide synthase and saving cardiac metabolism

https://asahikawa-med.repo.nii.ac.jp/records/2000268
https://asahikawa-med.repo.nii.ac.jp/records/2000268
9d6bda31-ed5f-42da-9fdd-00f77ef64fe5
名前 / ファイル ライセンス アクション
K551 K551 Kawaguchi Satoshi_TD.pdf (7.7 MB)
Item type 学位論文 / Thesis or Dissertation_02(1)
公開日 2025-01-16
タイトル
タイトル β3-Adrenergic receptor blockade reduces mortality in endotoxin-induced heart failure by suppressing induced nitric oxide synthase and saving cardiac metabolism
言語 en
言語
言語 eng
キーワード
言語 en
主題Scheme Other
主題 cardiac metabolism
キーワード
言語 en
主題Scheme Other
主題 endotoxin-induced heart failure
キーワード
言語 en
主題Scheme Other
主題 lipopolysaccharide
キーワード
言語 en
主題Scheme Other
主題 sepsis
キーワード
言語 en
主題Scheme Other
主題 β3-adrenergic receptor.
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_db06
資源タイプ doctoral thesis
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
その他(別言語等)のタイトル
その他のタイトル β3アドレナリン受容体遮断は、エンドトキシン起因の敗血症性心不全における誘導型一酸化窒素合成酵素を抑制し、心筋代謝を改善する事で生存率を改善する
言語 ja
著者 川口, 哲

× 川口, 哲

ja 川口, 哲

ja-Kana カワグチ, サトシ

en Kawaguchi, Satoshi

Search repository
bibliographic_information en : American journal of physiology. Heart and circulatory physiology

巻 318, 号 2, p. H283-H294
ISSN
収録物識別子タイプ PISSN
収録物識別子 0363-6135
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.1152/ajpheart.00108.2019
識別番号 その他
内容記述タイプ Other
内容記述 PMID: 31834837
言語 en
dissertation_number
学位授与番号 甲第551号
学位授与年月日
学位授与年月日 2020-09-30
学位名
言語 ja
学位名 博士(医学)
item_10_degree_grantor_32
言語 ja
学位授与機関名 旭川医科大学
item_10_description_33
内容記述タイプ Abstract
内容記述 The β3-adrenergic receptor (β3AR) is related to myocardial fatty acid metabolism and its expression has been implicated in heart failure. In this study, we investigated the role of β3AR in sepsis-related myocardial dysfunction using lipopolysaccharide (LPS)-induced endotoxemia as a model of cardiac dysfunction. We placed mice into three treatment groups and treated each with intraperitoneal injections of the β3AR agonist CL316243 (CL group), the β3AR antagonist SR59230A (SR group), or normal saline (NS group). Survival rates were significantly improved in the SR group compared with the other treatment groups. Echocardiography analyses revealed cardiac dysfunction within 6-12 h of LPS injections, but the outcome was significantly better for the SR group. Myocardial ATP was preserved in the SR group but was decreased in the CL-treated mice. Additionally, quantitative PCR analysis revealed that expression levels of genes associated with fatty acid oxidation and glucose metabolism were significantly higher in the SR group. Furthermore, the expression levels of mitochondrial membrane protein complexes were preserved in the SR group. Electron microscope studies showed significant accumulation of lipid droplets in the CL group. Moreover, inducible nitric oxide synthase (iNOS) protein expression and nitric oxide were significantly reduced in the SR group. The in vitro study demonstrated that β3AR has an independent iNOS pathway that does not go through the nuclear factor-κB pathway. These results suggest that blockading β3AR improves impaired energy metabolism in myocardial tissues by suppressing iNOS expression and recovers cardiac function in animals with endotoxin-induced heart failure.NEW & NOTEWORTHY Nitric oxide production through stimulation of β3-adrenergic receptor (β3AR) may improve cardiac function in cases of chronic heart failure. We demonstrated that the blockade of β3AR improved mortality and cardiac function in endotoxin-induced heart failure. We also determined that LPS-induced inducible nitric oxide synthase has a pathway that is independent of nuclear factor-κB, which worsened cardiac metabolism and mortality in the acute phase of sepsis. Treatment with the β3AR antagonist had a favorable effect. Thus, the blockade of β3AR could offer a novel treatment for sepsis-related heart failure.
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2025-01-16 02:02:03.283136
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3